Fate Therapeutics (FATE) Other Non-Current Assets (2012 - 2026)

Fate Therapeutics (FATE) has 15 years of Other Non-Current Assets data on file, last reported at $10.0 million in Q1 2026.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (changed N/A YoY) and the FY2025 annual result came in at $10.2 million, up 113533.33% from the prior year.
• Other Non-Current Assets slipped to $10.0 million in Q1 2026, from $10.2 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $15.2 million in Q2 2022 to a low of $9000.0 in Q3 2023.
• A 5-year average of $5.8 million and a median of $33000.0 in 2022 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 169088.89% — and 2024, when it slumped 99.94%.
• Tracing FATE's Other Non-Current Assets over 5 years: stood at $15.2 million in 2022, then fell by 0.33% to $15.2 million in 2023, then tumbled by 99.94% to $9000.0 in 2024, then soared by 113533.33% to $10.2 million in 2025, then dropped by 1.73% to $10.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $10.0 million (Q1 2026), $10.2 million (Q4 2025), and $9000.0 (Q4 2024), per Business Quant data.